Bioprocess

Human therapies are adapting to tackle increasingly complex immunological diseases and conditions. These therapies often rely on tightly controlled cell cultures in order to produce therapeutic drugs efficiently, such as monoclonal antibodies or culture of the patient’s own genetically-engineered cells, as part of an autologous cell therapy workflow.

Bioprocess
L

Large-molecule therapies cannot be synthesised in the same way as conventional drugs – instead, they can only be manufactured by living cells. Similarly, cell therapy workflows must culture the patient’s own individually genetically-engineered cells. These workflows are inherently complex and challenging.

The development of new biological processes is often carried out by scientists who want to be able to rapidly and reliably characterise culture performance under different process conditions. The commercial viability of these new therapies is heavily dependent on the productivity of the biology when later scaled out or scaled up. New sensors and improved user interactions with equipment can greatly speed up the pace of development and improve time to market for new therapies.

TTP offers disruptive solutions to improve performance and cost while enhancing human interactions with instruments that accelerate the biologic development timeline.

Explore More industries

Life Science

We work at the intersection of physics, engineering and the biological sciences, creating and developing new technology for the life science industry.

Drug Delivery

Pharmaceutical companies face substantial challenges, from constraints in health spending to weakening drug pipelines. Yet opportunities exist for those bold enough to adapt, ranging from connected devices that drive adherence to generic devices at cost points previously thought impossible.

Medical Devices

Disruptive change is rolling through the medical device industry as value-based healthcare and digitisation spread from niches to the mainstream. This is a challenging time, but it presents real opportunities for those ambitious companies prepared to reinvent themselves.

In-vitro Diagnostics

The diagnostic market is at a moment of change. New approaches, such as sequencing, are gaining traction; companion diagnostics are driving closer integration with therapy; continuous monitoring is enabling new diagnostic information; and market drivers are demanding low cost distribution of clinical quality data.

Biosensors

Emerging biosensor technologies are enabling the measurement and analysis of valuable trace markers, leading to improved clinical outcomes by allowing the accurate observation of previously undetectable physiological signals.

Smart Implants

Increasing numbers of people are suffering from chronic conditions. Through the creation of tiny, fully integrated real-time measurement systems, smart implants are bringing the benefits of laboratory-grade telemetry to their lives.

Digital Health

As with other industries, digital technology is touching every aspect of healthcare. But health is unique in its complexity, and innovation requires deep insight.

Medical Imaging

Medical imaging is required to meet the needs of advanced diagnostics and the demands of emerging markets, presenting the sector with sizeable rewards for innovation.

Surgical

Surgery is a fertile area for medical device innovation with remarkable developments occurring in minimally invasive and robotic assisted techniques. The future of the operating room relies on intraoperative technologies which improve clinical and economic values as measured by procedure outcome, workflow efficiency and patient safety.

Get in touch

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.